http://www.blacklistednews.com/news-5079-0-13-13--.html
The war on Terror and how it eventually infected us all.
According to multiple media reports, federal investigators concluded that the anthrax spores in the letters addressed to former Senate leader Tom Daschle (D-SD) and Senate Judiciary Chairman Patrick Leahy (D-VT) could only have been produced in a state-run lab. The weaponized version of the pathogen contained as many as one trillion spores per gram, a concentration sufficient enough to kill half the American population if widely distributed.
But rather than giving pause to Pentagon weaponeers, Big Pharma who profit handsomely from vaccine production, the $100 billion agribusiness empire that drives research and the politicians who do their bidding, decades-long U.S. biowar programs have miraculously morphed overnight into a new growth industry: "biodefense."
What had once been Washington's dirty little secret has now blossomed into a $50 billion cash-cow for academic and corporate grifters, according to the Washington, D.C.-based Center for Arms Control and Non-Proliferation.
As the Bulletin of the Atomic Scientists pointed out last year, "massive U.S. biodefense spending and a buildup of high-containment laboratories throughout the country might have created an internal security risk that no outside terrorist group could ever duplicate. Nearly two dozen new federal and many more new private biosafety level 3 and 4 laboratories have been built in recent years, meaning a large cadre of scientists has access to extraordinarily lethal material."
Indeed, under the auspices of the Department of Homeland Security (DHS), the new National Biodefense Analysis and Countermeasures Center (NBACC) opened in 2008 at USAMRIID. The center conducts inherently dual-use classified research and is currently managed by the spooky Battelle National Biodefense Institute.
